A detailed history of Profund Advisors LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 78,227 shares of MRNA stock, worth $2.88 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
78,227
Previous 56,218 39.15%
Holding current value
$2.88 Million
Previous $6.68 Million 21.69%
% of portfolio
0.2%
Previous 0.25%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$63.64 - $125.14 $1.4 Million - $2.75 Million
22,009 Added 39.15%
78,227 $5.23 Million
Q2 2024

Aug 13, 2024

BUY
$101.21 - $166.61 $983,659 - $1.62 Million
9,719 Added 20.9%
56,218 $6.68 Million
Q1 2024

May 08, 2024

SELL
$85.37 - $115.44 $549,270 - $742,740
-6,434 Reduced 12.15%
46,499 $4.95 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $705,456 - $1.06 Million
10,149 Added 23.72%
52,933 $5.26 Million
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $838,477 - $1.1 Million
8,697 Added 25.51%
42,784 $4.42 Million
Q2 2023

Aug 10, 2023

BUY
$118.5 - $160.53 $471,511 - $638,748
3,979 Added 13.22%
34,087 $4.14 Million
Q1 2023

May 11, 2023

SELL
$135.66 - $197.02 $3.44 Million - $5 Million
-25,353 Reduced 45.71%
30,108 $4.62 Million
Q4 2022

Feb 02, 2023

SELL
$118.38 - $210.04 $154,130 - $273,472
-1,302 Reduced 2.29%
55,461 $9.96 Million
Q3 2022

Nov 04, 2022

SELL
$118.07 - $194.18 $521,869 - $858,275
-4,420 Reduced 7.22%
56,763 $6.71 Million
Q2 2022

Aug 01, 2022

SELL
$117.13 - $176.59 $1.17 Million - $1.76 Million
-9,974 Reduced 14.02%
61,183 $8.74 Million
Q1 2022

May 10, 2022

SELL
$126.46 - $235.05 $1.9 Million - $3.53 Million
-15,014 Reduced 17.42%
71,157 $12.3 Million
Q4 2021

Feb 08, 2022

SELL
$225.82 - $368.51 $2.07 Million - $3.38 Million
-9,175 Reduced 9.62%
86,171 $21.9 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $2.4 Million - $5.24 Million
10,816 Added 12.8%
95,346 $36.7 Million
Q2 2021

Aug 12, 2021

SELL
$129.91 - $234.98 $297,623 - $538,339
-2,291 Reduced 2.64%
84,530 $19.9 Million
Q1 2021

May 14, 2021

BUY
$109.18 - $185.98 $153,288 - $261,115
1,404 Added 1.64%
86,821 $11.4 Million
Q4 2020

Feb 09, 2021

BUY
$65.74 - $169.86 $450,384 - $1.16 Million
6,851 Added 8.72%
85,417 $8.92 Million
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $710,658 - $1.24 Million
13,078 Added 19.97%
78,566 $5.56 Million
Q2 2020

Aug 03, 2020

BUY
$29.67 - $80.0 $791,417 - $2.13 Million
26,674 Added 68.72%
65,488 $4.21 Million
Q1 2020

May 15, 2020

SELL
$17.78 - $31.58 $251,907 - $447,425
-14,168 Reduced 26.74%
38,814 $1.16 Million
Q4 2019

Feb 18, 2020

BUY
$13.93 - $21.28 $81,755 - $124,892
5,869 Added 12.46%
52,982 $1.04 Million
Q3 2019

Nov 12, 2019

BUY
$12.26 - $18.07 $577,605 - $851,331
47,113 New
47,113 $750,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.